MMP2 and central nervous system cancer: MiR‐129‐5p overexpression obviously reduced the MMP‐2 and MMP‐9 protein levels and the luciferase activities of NF‐κB, indicating that miR‐129‐5p blocked the NF‐κB pathways to suppress glioma angiogenesis and growth (Figure 4).